Breztri safety study for COPD and asthma patients in Korea
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study collects information on how Breztri (a medicine for COPD and asthma) works in real-life patients who have just started taking it. It helps ensure the medicine is safe and effective for people like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with COPD or asthma.
- You have just started taking Breztri as prescribed in Korea.
- You are not pregnant or breastfeeding.
- You are not in another clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called BBT002 in healthy volunteers and people with chronic obstructive pulmonary disease (COPD), a lung condition that makes breathing hard. It aims to see if the drug is safe and how the body processes it.
This trial looks at how long-term health conditions like heart disease, diabetes, or high blood pressure might affect breathing problems. The goal is to better understand and help people with both issues.
This study tests an experimental medication for chronic obstructive pulmonary disease (COPD) in two parts: first in healthy volunteers, then in people with COPD. It aims to see if the drug is safe and how well it works.
This study compares simple breathing tests (oscillometry and FeNO) used by your primary care doctor against a specialist's diagnosis to see if they can accurately tell if you have asthma or COPD. If you have symptoms like wheezing, cough, or shortness of breath but haven't been diagnosed yet, this trial may help improve how these conditions are found.
This study looks at people with asthma or COPD to better understand the disease and how it affects them. It may help improve future treatments.
This study is testing whether an investigational drug called GSK5784283 can improve asthma control compared to a placebo. It is for people with uncontrolled asthma who are already on standard daily asthma medications.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.